Navigating Your 401(k) Options When Changing Jobs
Finance

Navigating Your 401(k) Options When Changing Jobs

authorBy Suze Orman
DateJul 10, 2026
Read time3 min

When transitioning to a new professional role, managing your 401(k) retirement savings might not be your immediate priority. However, neglecting these accounts can lead to unforeseen consequences, including automatic cash-outs, fund transfers, or leaving your assets in low-growth investments without your awareness. Understanding the regulations governing these accounts is critical to safeguarding your financial future and maximizing growth potential.

The disposition of your 401(k) balance upon leaving an employer is dictated by several factors, including the account balance and whether it's a traditional or Roth 401(k). For balances below $1,000, employers typically have the discretion to issue a direct cash payout. While this option provides immediate liquidity, it also carries the risk of a 10% early withdrawal penalty, in addition to applicable taxes. To mitigate these adverse financial impacts, individuals have a 60-day window to transfer these funds into an Individual Retirement Account (IRA), thereby avoiding penalties and taxes.

For balances ranging from $1,000 to $7,000, employers often choose to automatically roll over the funds into an IRA, primarily to reduce their administrative burdens. These automatic rollovers commonly place funds into low-risk, low-yield options such as money market funds. Savers should proactively consider reallocating these funds into growth-oriented investments, such as index or target-date funds, to enhance long-term returns. If your balance exceeds $7,000, employers usually cannot compel you to withdraw your funds, allowing you the flexibility to retain the money in your former employer's plan or initiate a rollover to an IRA or a new employer's retirement scheme at your convenience. While these balance-based rules apply uniformly to both traditional and Roth 401(k)s, their post-rollover treatment differs significantly.

The rules governing Roth 401(k)s are particularly stringent following employment changes. Traditional 401(k)s can be rolled into traditional IRAs and, in some cases, subsequently transferred into a new employer’s retirement plan via a “reverse rollover.” However, Roth 401(k)s are exclusively rolled into Roth IRAs, and currently, these funds cannot be transferred back into an employer-sponsored plan. This inflexibility has prompted legislative efforts, such as the “Retirement Rollover Flexibility Act,” to allow Roth IRA funds to be rolled into workplace retirement plans, aiming to provide greater portability and ease of management for workers' retirement savings.

To avoid costly errors, it's crucial to proactively manage your 401(k) when changing jobs. Opting for a rollover into an IRA or your new employer's plan is generally more advantageous than cashing out, which incurs taxes and penalties. Be vigilant for any checks issued by your former employer and act promptly to deposit them into an IRA within the 60-day limit. Should your funds be automatically rolled into an IRA, ensure they are invested wisely to prevent them from stagnating in low-growth accounts. Diligent attention to these details can help preserve and grow your retirement nest egg.

More Articles
Finance
Zurn Elkay Water Solutions: Strong Performance vs. Valuation Limits
Zurn Elkay Water Solutions Corporation (ZWS) maintains a 'Hold' rating due to a combination of strong operational performance and a stretched market valuation. The company achieved 11.4% revenue growth and significant profit improvements through robust demand and a focus on high-margin products. Despite this, its stock trades at higher multiples than most competitors, suggesting limited short-term upside. Investors should exercise caution, as upcoming Q2 2026 results are anticipated to show continued growth, but the premium pricing remains a concern.
By Strive MasiyiwaJul 10, 2026
Finance
Mueller Water Products: Premium Margins Support a Compelling Valuation
Mueller Water Products, Inc. (MWA) is considered a cautious buy due to its discounted valuation, strong margins, and exposure to essential municipal water infrastructure. Despite slow revenue growth and challenges in residential construction, the company's Q2 results showed notable revenue and EBITDA growth. MWA's superior EBIT and EBITDA margins compared to competitors justify its valuation, even with modest top-line expansion.
By David RubensteinJul 10, 2026
Finance
Maximizing Retirement Contributions for a Secure Future
A Vanguard study reveals that a mere 14% of defined contribution plan participants maximize their annual contributions. While high-income earners are more likely to achieve this, even those with moderate incomes can strive for this goal. Early and consistent maximization of contributions, coupled with the power of compounding, significantly enhances retirement security. Strategic financial planning, leveraging employer matching, and balancing other financial goals are crucial for optimizing retirement savings.
By Robert KiyosakiJul 10, 2026
Finance
RxSight: A Promising Investment Opportunity Among Small-Cap Equities
RxSight (RXST) presents a compelling investment case, mirroring the quantitative attributes of several high-performing small-cap companies I've previously assessed. This firm stands out as a Net Current Asset Value (NCAV) opportunity, trading below its current asset value while actively pursuing a growth trajectory. My investment hypothesis is rooted in observed historical trends where cash-rich, yet unprofitable, small-cap enterprises frequently overcome operational hurdles before their financial reserves deplete. It is prudent for investors to diversify their portfolios when considering such equities.
By Strive MasiyiwaJul 10, 2026
Finance
Cue Biopharma: High Risk, Low Reward in a Single-Asset Biotech
Cue Biopharma (CUE) faces significant challenges due to its overvaluation and high risk of dilution. The company's $86 million enterprise value is tied to a single in-licensed Phase 2 anti-IgE asset, CUE-221, which it does not control. With only three quarters of funding, substantial dilution is imminent, threatening to triple the share count. Despite a de-risked target and recent insider buying, the current share price of $30.25 far exceeds its fair value.
By David RubensteinJul 10, 2026